Today, Wellpath announced that it hired Dr. Neil Schamban to serve as the president of our new Medication-Assisted Treatment Division, devoted to opioid use disorder.
“We are excited to begin a new chapter with Dr. Schamban,” said Wellpath CEO, Jorge Dominicis. “Our company is devoted to combatting the opioid crisis and we know Dr. Schamban will help Wellpath lead the way in treating our patients who are impacted by this epidemic.”
Dr. Schamban, an Emergency Medicine Physician, started his career in academics as the Division Chairman of Newark Beth Israel Medical Center, overseeing both the adult emergency department and Children’s Hospital. In 2008, Dr. Schamban moved to Alabama and founded Pegasus Emergency Group which provided care to several hundred thousand patients in the Southeastern United States by 2013. In 2014 Dr. Schamban continued his career as medical leader at Island Medical which experienced significant growth as a national platform for emergency medicine during his tenure. Dr. Schamban is dedicated to compassionate, quality care to all patients and wellness to providers in a positive work environment. He is passionate about providing access and solutions to the myriad patients who suffer from opiate addiction and achieve better outcomes allowing them to live purposeful and quality lives.
Wellpath is a leading healthcare company transforming public health by delivering hope and healing to those who need it most.
Wellpath holds patients at the center of everything we do. Our company nurtures innovation and values compassionate service. With nearly 16,000 clinicians and professionals in 33 states across the U.S. and Australia, Wellpath focuses on delivering high quality healthcare. Every day, Wellpath provides medical and behavioral health services for more than 300,000 patients located in state hospitals, forensic treatment and civil commitment centers, as well as local, state and federal correctional facilities. Learn more at https://wellpathcare.com.